A Massachusetts-based biotech company is making waves Tuesday morning after the company reportedly received regulatory guidance from the U.K.’s regulatory agency for AXA1125...

To read the full story on AllPennyStocks.com, click here.

Axcella Health (NASDAQ:AXLA)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Axcella Health
Axcella Health (NASDAQ:AXLA)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Axcella Health